Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KPS-0373 in Spinocerebellar Degeneration
NCT01384435Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rovatirelin in spinocerebellar degeneration (SCD), sponsored by Kissei Pharmaceutical Co., Ltd.. Status: completed.
02
Drugs
rovatirelin
03
Conditions
spinocerebellar degeneration (SCD)
Beyond the preview
Go deeper on NCT01384435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01384435.